Kathleen W. Scotto, PhD

KathleenScottoVice Chancellor for Research, Rutgers Biomedical and Health Sciences
Dean, Graduate School of Biomedical Sciences
Professor of Pharmacology, Robert Wood Johnson Medical School
Member, Rutgers Cancer Institute of New Jersey
Rutgers, The State University of New Jersey
New Brunswick, New Jersey

Kathleen W. Scotto, PhD, is the vice chancellor for research and dean of the Graduate School of Biomedical Sciences at Rutgers Biomedical and Health Sciences. She received her doctorate from the Cornell Graduate School of Medical Sciences in 1984, and was a postdoctoral fellow at the Rockefeller University until 1988. Prior to joining UMDNJ-RWJMS in the fall of 2004, Dr. Scotto was an associate professor of molecular pharmacology and experimental therapeutics at Memorial Sloan Kettering Cancer Center in New York (1989-2001) and a professor of pharmacology at the Fox Chase Cancer Center in Philadelphia (2001-2004).

In addition to her administrative roles, Dr. Scotto maintains an active NIH-funded laboratory at RCINJ. She is internationally recognized for her work on the regulation of drug resistance genes that impact sensitivity of cancer cells to therapeutic agents. She is the author of numerous articles, reviews and patents in this area. The Scotto lab studies the regulation of alternative splicing, particularly as it relates to the cancer phenotype. Dr. Scotto serves on multiple committees within the cancer field, and is on the editorial board of two cancer journals. Combining her dedication to the nurturing and training of young scientists with her passion for the translation of basic science into new disease treatments, she is currently involved in the development of a novel New Jersey statewide infrastructure to develop and train the clinical/translational research teams of the future.

Jose G. Treviño, MD

JoseTrevinoAssistant Professor, Department of Surgery
The University of Florida- Gainesville
Gainesville, Florida


 Jose Treviño, MD, joined the University of Florida’s division of general surgery’s pancreatobiliary service in August 2011. Dr. Treviño earned his medical degree and completed his surgical residency at University of Illinois at Chicago. He was a research fellow in cancer biology at University of Texas MD Anderson Cancer Center in Houston and a clinical/research fellow in surgical oncology/tumor biology at H. Lee Moffitt Cancer Center and Research Institute in Tampa. Although his clinical focus is on liver, bile duct, and pancreas surgery, his basic science research interests include pancreatic cancer biology with an emphasis on the tumor microenvironment’s contribution to cancer signaling and chemoresistance.